1. Home
  2. ABM vs SRPT Comparison

ABM vs SRPT Comparison

Compare ABM & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABM Industries Incorporated

ABM

ABM Industries Incorporated

HOLD

Current Price

$39.15

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.91

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABM
SRPT
Founded
1909
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
ABM
SRPT
Price
$39.15
$17.91
Analyst Decision
Buy
Hold
Analyst Count
5
29
Target Price
$47.80
$25.85
AVG Volume (30 Days)
323.3K
2.6M
Earning Date
06-05-2026
05-06-2026
Dividend Yield
2.92%
N/A
EPS Growth
102.34
N/A
EPS
0.64
2.88
Revenue
$8,745,900,000.00
$2,198,237,000.00
Revenue This Year
$5.97
N/A
Revenue Next Year
$3.45
N/A
P/E Ratio
$62.27
$5.99
Revenue Growth
4.62
15.58
52 Week Low
$36.96
$10.42
52 Week High
$52.94
$43.92

Technical Indicators

Market Signals
Indicator
ABM
SRPT
Relative Strength Index (RSI) 43.56 43.95
Support Level $38.29 $17.11
Resistance Level $41.17 $18.10
Average True Range (ATR) 0.98 0.77
MACD -0.02 -0.08
Stochastic Oscillator 39.35 32.79

Price Performance

Historical Comparison
ABM
SRPT

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: